Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
27
Number of overlapping holdings
14.1%
% of IBB's 212 holdings also in FBT
90.0%
% of FBT's 31 holdings also in IBB
Overlap by Weight
Sector Drift (IBB minus FBT)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IBB |
Weight in FBT |
Overlap | |
|---|---|---|---|---|
 |
GILEAD SCIENCES INC | 9.9% | 3.6% | 3.6% |
|
VERTEX PHARMACEUTICALS INC | 8.0% | 3.2% | 3.2% |
 |
ARGENX SE ADR | 3.1% | 3.8% | 3.1% |
|
ALNYLAM PHARMACEUTICALS INC | 3.2% | 2.9% | 2.9% |
|
AMGEN INC | 6.9% | 2.8% | 2.8% |
Position Highlights (Non-Overlapping Exposures)
IBB Overweight Relative to FBT
|
GILEAD SCIENCES INC | 6.3% |
|
VERTEX PHARMACEUTICALS INC | 4.8% |
|
AMGEN INC | 4.2% |
|
IQVIA HOLDINGS INC | 3.7% |
|
REGENERON PHARMACEUTICALS | 2.9% |
|
INSMED INC | 1.2% |
|
BIO-TECHNE CORPORATION | 1.2% |
|
VAXCYTE, INC. | 1.1% |
|
CHARLES RIVER LABORATORIES | 1.0% |
|
ADVENTRX PHARMACEUTICALS INC | 1.0% |
IBB Underweight Relative to FBT
|
CORCEPT THERAPEUTICS INC | -4.1% |
|
ACADIA PHARMACEUTICALS INC | -3.6% |
|
CATALYST PHARMACEUTICAL PART | -3.6% |
|
EXELIXIS INC | -3.5% |
 |
ALKERMES PLC | -3.1% |
|
REPLIGEN CORP | -3.0% |
|
EXACT SCIENCES CORP | -2.9% |
|
INTRA-CELLULAR THERAPIES INC | -2.9% |
|
HALOZYME THERAPEUTICS INC | -2.4% |
|
NEUROCRINE BIOSCIENCES INC | -2.4% |